French target US Vaccine Maker with Possible Manslaughter
US VACCINE MAKER TARGET OF HOMOCIDE INVESTIGATION
By Jim Kouri
Posted 1:00 AM Eastern, March 3, 2008
In a criminal case guaranteed to send shockwaves throughout the international pharmaceutical industry, French authorities are targeting a US-based drug company and its executives in a homicide investigation.
The multi-billion dollar corporation GlaxoSmithKline and one of its key executives are facing possible manslaughter charges stemming from allegations that the company failed to fully disclose side effects from an anti-Hepatitis "B" vaccine distributed between 1994 and 1998.
Also being investigated is the French-based drug company Sanofi Pasteur, which also sold doses of the Hepatitis "B" vaccine, according to French news sources
"The investigations are in response to allegations that the companies failed to fully disclose side effects from an anti-hepatitis B drug used between 1994 and 1998," stated the French source.
Visit the link for the full story
Almost two-thirds of the French citizens and many new-borns were vaccinated with this vaccine during the 90's before the program was halted. There are also at least 30 civil suits.